openPR Logo
Press release

Zika Vaccines Market - Global Industry Insights 2025

06-13-2017 09:26 AM CET | Health & Medicine

Press release from: Zika Vaccines Market

Zika vaccines are developed for immunization & prevention against diseases caused by Zika virus. This virus belongs to genus Flavivirus and is transmitted by Aedes mosquitoes. The virus can also be transmitted through blood transfusion, sexual contact or from infected pregnant women to the fetus. Diagnosis of this infection is confirmed by detecting viral DNA through PCR. However, only 1 in 4 people with zika infection are prone to develop symptoms. In November 2016, the World Health Organization (WHO) declared that zika infection no longer constitutes a Public Health Emergency of International Concern (PHEIC) as major cases of zika virus were asymptomatic.

A sample of this report is available upon request: https://www.coherentmarketinsights.com/insight/request-sample/413

In April 2015, a major ongoing outbreak of Zika virus was registered in Brazil, which later affected the population in South and Central America. This outbreak caused mild illness (fever, rashes, joint pains, conjunctivitis, nausea, and muscle pain), though the recent outbreaks showed severe complications such as microcephaly, Guillain-Barré syndrome, and various congenital neurological abnormalities in infants who were born to infected mothers. The link between zika virus and microcephaly and Guillain-Barré syndrome was identified and reported in 2015 in Brazil.

According to the Centers for Disease Control and Prevention (CDC), 70 new zika virus infection cases were reported in the U.S. in 2015, which increased to 41,181 cases in 2016. Lack of reporting is a major factor for lower incidence rate in 2015. Increase in awareness can result in more diagnosis and reporting thus generating growth of the global zika vaccines market.

Researchers at the Queensland University of Technology found that the extract of San Francisco plant (Codiaeum variegatum) found in Australia, can kill the zika virus. This extract can arrest the virus and stop it from replicating without causing any damage to the host cells.

Zika Vaccines Market Taxonomy:

There are different types of vaccines that provide protection against Zika virus:

DNA-based vaccines
Inactivated vaccines
Live-attenuated vaccines
mRNA vaccines
Genetically engineered vaccines

Global market by application:

Therapeutic Vaccines
Preventive Vaccines

Global market by end user:

Hospitals
Clinics

Continuous increase in human clinical trials and rise in number of zika
cases will drive the growth of Zika vaccines market

As of March 2016, 67 companies and research institutions were working on various kinds of R&D projects and clinical trials aided to develop effective vaccines against zika virus. The FDA approved the first human clinical trial for GLS–5700 in June 2016, a zika vaccine being developed by Inovio Pharmaceuticals. Further in 2017, a grant was approved for phase 2 clinical trials for a DNA vaccine conducted by NIAID’s Vaccine Research Center (VRC).

Increasing awareness among the population would aid in controlling the incidence rate of zika infection. The WHO implemented a global framework for creating public awareness through its Zika Strategic Response Framework and Joint Plan in February 2016. This plan outlines all the points to be taken care of at the time of infections. In June 2016, WHO Regional Office for Europe developed a training curriculum to increase awareness by the publication of Zika Risk Assessment for European Region.

Browse Global Strategic Business Report : https://www.coherentmarketinsights.com/ongoing-insight/zika-vaccines-market-413

High investment costs required for R&D and the development of effective zika virus vaccines serves as a restraining factor for the global zika vaccines market.

While major of the Zika virus cases occur in tropical regions such as Brazil, Paraguay, Venezuela, Colombia and Suriname, there are higher chances of mosquito infections in tropical areas of the U.S. like Texas and Florida. According to Pan American Health Organization, around 1,246 suspected and confirmed cases were reported between epidemiological week (EW) 10 and EW 14 of 2016 in the sub region which involves Brazil, Argentina, Peru and Ecuador.

Competitive Landscape

Some key players operating in the zika vaccines market are Cerus Corporation, Biken Inc, GlaxoSmithKline plc, Bharat Biotech International Pvt. Ltd, GeneOne Life Science, Inovio Pharmaceuticals, Immunovaccine Inc., NewLink Genetics Corp. and Sanofi S.A. The companies launched various R&D measures and clinical trials to attain immunogenicity against zika virus. In February 2016, Sanofi S.A launched a vaccine research and development project, with the introduction of Dengvaxia (Dengue vaccine) that will aid the company understand the Zika virus and develop an effective vaccine against it. Likewise, Inovio Pharmaceuticals initiated a clinical study of zika vaccine (GLS-5700) in Puerto Rico in August 2016. This trial may provide a potential push to Inovio’s vaccine if positive results are reported as there was a rapid progression of zika outbreak in Puerto Rico at that time. This could benefit the trial in assessing true efficacy and safety of the vaccine. Rapid progression in clinical trials and approval would augment the zika vaccines market growth.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com
Visit Coherent Market Insights Blog @ https://blog.coherentmarketinsights.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/coherent-market-insights

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Zika Vaccines Market - Global Industry Insights 2025 here

News-ID: 574379 • Views: 202

More Releases from Zika Vaccines Market

Zika Vaccines Market - Global Industry Insights, Trends, Outlook, and Opportunit …
Zika vaccines are developed for immunization & prevention against diseases caused by Zika virus. This virus belongs to genus Flavivirus and is transmitted by Aedes mosquitoes. The virus can also be transmitted through blood transfusion, sexual contact or from infected pregnant women to the fetus. Diagnosis of this infection is confirmed by detecting viral DNA through PCR. However, only 1 in 4 people with zika infection are prone to develop

More Releases for Brazil

Wine in Brazil
Latest Report on Wine in Brazil Similar to other alcoholic drinks, wine saw a total volume decline in 2016, with sales falling by 3%. Although this decline was slower than that seen in the previous year, of 4%, it is clear that the negative economic situation continued to affect consumers’ demand for wine. Since it is perceived by many as a non-essential product, other products and types of alcoholic drinks seemed
Alcoholic Drinks in Brazil
Latest Report on Alcoholic Drinks in Brazil Total volume sales of alcoholic drinks continued to decline in Brazil in both the on-trade and off-trade channels in 2016. Consumers had less available income; therefore were forced to make more rational decisions on what to purchase, taking into consideration their budget and the necessity of each product. For this reason, consumption frequency reduced considerably in almost all categories, and also a downgrade to
Brazil Juice Industry
Brazil Juice Industry Juice in Brazil was directly affected by the unstable economic situation and consumers’ shrinking disposable incomes. After registering a series of double-digit growth rates in off-trade volume terms earlier in the review period, the category registered a flat performance in 2015 and grew by just 2% in 2016. The two most important categories within juice in off-trade volume terms, nectars and juice drinks (up to 24% juice), faced
Brazil: Country Intelligence Report
Brazil: Country Intelligence Report Summary "Brazil: Country Intelligence Report", by GlobalData provides an executive-level overview of the telecommunications market in Brazil today, with detailed forecasts of key indicators up to 2021. Published annually, the report provides the detailed analysis of the near-term opportunities, competitive dynamics and evolution of demand by service type and technology/platform across the fixed telephony, broadband, and mobile, as well as a review of key regulatory trends. SAMPLE REPORT: https://www.reportsandmarkets.com/sample-request/brazil-country-intelligence-report-1613311 GlobalData
Packaged Water in Brazil
ReportsWorldwide has announced the addition of a new report title Packaged Water in Brazil to its growing collection of premium market research reports. Packaged Water in Brazil industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis: Essential resource
Airlines in Brazil 2017
ReportsWorldwide has announced the addition of a new report title Airlines in Brazil 2017 to its growing collection of premium market research reports. Airlines in Brazil industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Synopsis: Essential resource for top-line data